Use of amnion‐derived cellular cytokine solution for the treatment of gingivitis: A 2‐week safety, dose‐ranging, proof‐of‐principle randomized trial

BACKGROUND: A 6‐week Phase I clinical trial was performed to primarily evaluate the safety and secondarily determine the preliminary efficacy of a novel biological solution, ST266, comprised of a mixture of cytokines, growth factors, nucleic acids, and lipids secreted by cultured amnion‐derived mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasturk, Hatice, Steed, David, Tosun, Emre, Martins, Melissa, Floros, Constantinos, Nguyen, Daniel, Stephens, Danielle, Cugini, Maryann, Starr, Jacqueline, Van Dyke, Thomas E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Translational Periodontology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518950/
https://www.ncbi.nlm.nih.gov/pubmed/33586783
http://dx.doi.org/10.1002/JPER.20-0800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518950/
https://www.ncbi.nlm.nih.gov/pubmed/33586783
http://dx.doi.org/10.1002/JPER.20-0800

Ejemplares similares